Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors

Journal of Cellular Biochemistry

Volumn 112, Issue 12, 2011, Pages 3704-3713

  Costa Rodrigues, João ^a   Fernandes, Anabela ^a,b   Fernandes, Maria H ^a  

^a Portugal   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Cell to cell communication; Co cultures; Osteoclast; Osteosarcoma

Indexed keywords

ACTIN; BONE MORPHOGENETIC PROTEIN 2; CALCITONIN RECEPTOR; CALCIUM PHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATASE; SPHINGOSINE 1 PHOSPHATE; TARTARATE ACID RESISTANT PHOSPHATASE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ADULT; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL COMMUNICATION; CELL FUNCTION; CELL INTERACTION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MULTINUCLEAR CELL; OSTEOBLAST; OSTEOCLAST; OSTEOSARCOMA; OSTEOSARCOMA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECIPROCAL OSTEOBLASTIC MODULATION; RECIPROCAL OSTEOCLASTIC MODULATION;

BASE SEQUENCE; BONE NEOPLASMS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DNA PRIMERS; HUMANS; OSTEOBLASTS; OSTEOCLASTS; OSTEOSARCOMA; POLYMERASE CHAIN REACTION;

EID: 80055014275     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23295     Document Type: Article

References (50)

1. Angel NZ, Walsh N, Forwood MR, Ostrowski MC, Cassady AI, Hume DA,. 2000. Transgenic mice overexpressing tartarate-resistant acid phosphatase exhibit an increased rate of bone turnover. J Bone Miner Res 15: 103-110. (Pubitemid 30026937)
2. Avnet S, Longhi A, Salerno M, Halleen JM, Perut F, Granchi D, Ferrari S, Bertoni F, Giunti A, Baldini N,. 2008. Increased osteoclast activity is associated with aggressiveness of osteosarcoma. Int J Oncol 33: 1231-1238.
3. Benedikt MB, Mahlum EW, Shogren KL, Subramaniam M, Spelsberg TC, Yaszemski MJ, Maran A,. 2010. 2-methoxyestradiol-mediated anti-tumor effect increases osteoprotegerin expression in osteosarcoma cells. J Cell Biochem 109: 950-956.
4. Blair HC, Sidonio RF, Friedberg RC, Khan NN, Dong SS,. 2000. Proteinase expression during differentiation of human osteoclasts in vitro. J Cell Biochem 78: 627-637. (Pubitemid 30620708)
5. Bradford MM,. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. Buckley KA, Hipskind RA, Gartland A, Bowler WB, Gallagher JA,. 2002. Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kB ligand. Bone 31: 582-590. (Pubitemid 35449700)
7. Chen D, Zhao M, Mundy GR,. 2004. Bone morphogenetic proteins. Growth Factors 22: 233-241. (Pubitemid 40136452)
8. Costa-Rodrigues J, Fernandes MH,. 2011. Paracrine-mediated differentiation and activation of human hematopoietic osteoclast precursor cells by skin and gingival fibroblasts. Cell Prolif 44: 264-273.
9. Costa-Rodrigues J, Teixeira CA, Sampaio P, Fernandes MH,. 2010. Characterisation of the osteoclastogenic potential of human osteoblastic and fibroblastic conditioned media. J Cell Biochem 109: 205-216.
10. Costa-Rodrigues J, Fernandes A, Fernandes MH,. 2011. Spontaneous and induced osteoclastogenic behaviour of human peripheral blood mononuclear cells and their CD14+ and CD14- cell fractions. Cell Prolif (in press).
11. Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS,. 2008. The cell biology of bone metabolism. J Clin Pathol 61: 577-587. (Pubitemid 351678208)
12. Galvin RJ, Cullison JW, Avioli LV, Osdoby PA,. 1994. Influence of osteoclasts and osteoclast-like cells on osteoblast alkaline phosphatase activity and collagen synthesis. J Bone Miner Res 9: 1167-1178. (Pubitemid 24238347)
13. Garimella R, Tague SE, Zhang J, Belibi F, Nahar N, Sun BH, Insogna K, Wang J, Anderson HC,. 2008. Expression and synthesis of bone morphogenetic proteins by osteoclasts: A possible path to anabolic bone remodeling. J Histochem Cytochem 56: 569-577. (Pubitemid 351702301)
14. Gomes PS, Santos JD, Fernandes MH,. 2008. Cell-induced response by tetracyclines on human bone marrow colonized hydroxyapatite and bonelike. Acta Biomater 4: 630-637.
15. Gray C, Boyde A, Jones SJ,. 1996. Topographically induced bone formation in vitro: Implications for bone implants and bone grafts. Bone 18: 115-123. (Pubitemid 26092591)
16. Hall TJ, Schaeublin M, Jeker H, Fuller K, Chambers TJ,. 1995. The role of reactive oxygen intermediates in osteoclastic bone resorption. Biochem Biophys Res Commun 207: 280-287.
17. Hashizume M, Hayakawa N, Mihara M,. 2008. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology (Oxford) 47: 1635-1640.
18. Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ, Cox TM,. 1996. Mice lacking tartarate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122: 3151-3162. (Pubitemid 26371980)
19. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL,. 2002. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 99: 9445-9449. (Pubitemid 34764633)
20. Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, Kitaura H, Yoshida N, Nakayama K,. 2002. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem 277: 47366-47372. (Pubitemid 36159251)
21. Izbicka E, Niewolna M, Yoneda T, Lowe C, Boyce B, Mundy G,. 1994. pp60 c-src expression and activity in MG-63 osteoblastic cells modulated by PTH but not required for PTH-mediated adenylate cyclase response. J Bone Miner Res 9: 127-132.
22. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y,. 2000. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 27: 479-486.
23. Kawashima M, Fujikawa Y, Itonaga I, Takita C, Tsumura H,. 2009. The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro. Mod Rheumatol 19: 192-198.
24. Kim HJ, Lee Y, Chang EJ, Kim HM, Hong SP, Lee ZH, Ryu J, Kim HH,. 2007. Suppression of osteoclastogenesis by N,N-dimethyl- D -erythro-sphingosine: A sphingosine kinase inhibition-independent action. Mol Pharmacol 72: 418-428. (Pubitemid 47124122)
25. Knowles HJ, Athanasou NA,. 2008. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. J Pathol 215: 56-66. (Pubitemid 351619876)
26. Lagasse E, Weissman IL,. 1997. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89: 1021-1031. (Pubitemid 127678736)
27. Laulederkind SJ, Kirtikara K, Raghow R, Ballou LR,. 2000. The regulation of PGE(2) biosynthesis in MG-63 osteosarcoma cells by IL-1 and FGF is cell density-dependent. Exp Cell Res 258: 409-416. (Pubitemid 30483519)
28. Le Heron L, Guillaume C, Velard F, Braux J, Touqui L, Moriceau S, Sermet-Gaudelus I, Laurent-Maquin D, Jacquot J,. 2010. Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. J Cyst Fibros 9: 69-72.
29. Legendre F, Dudhia J, Pujol JP, Bogdanowicz P,. 2003. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression. J Biol Chem 278: 2903-2912. (Pubitemid 36801195)
30. Matsuo K, Irie N,. 2008. Osteoclast-osteoblast communication. Arch Biochem Biophys 473: 201-209.
31. Matsusaki K, Katayama K, Takahashi Y, Nakamura I, Udagawa N, Tsurukai T, Nishinakamura R, Toyama Y, Yabe Y, Hori M, Takahashi N, Suda T,. 1999. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene. Endocrinology 140: 925.
32. Michael H, Harkonen PL, Kangas L, Vaananen HK, Hentunen TA,. 2007. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro. Br J Pharmacol 151: 384-395. (Pubitemid 46842673)
33. Miyamoto N, Higuchi Y, Mori K, Ito M, Tsurudome M, Nishio M, Yamada H, Sudo A, Kato K, Uchida A, Ito Y,. 2002. Human osteosarcoma-derived cell lines produce soluble factor(s) that induces differentiation of blood monocytes to osteoclast-like cells. Int Immunopharmacol 2: 25-38. (Pubitemid 33086801)
34. Mori G, Cantatore FP, Brunetti G, Oranger A, Colaianni G, Quarta L, Corrado A, Colucci S, Grano M,. 2007. Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis. Ann N Y Acad Sci 1117: 159-164. (Pubitemid 350191266)
35. Motokawa M, Kaku M, Tohma Y, Kawata T, Fujita T, Kohno S, Tsutsui K, Ohtani J, Tenjo K, Shigekawa M, Kamada H, Tanne K,. 2005. Effects of cyclic tensile forces on the expression of vascular endothelial growth factor (VEGF) and macrophage-colony-stimulating factor (M-CSF) in murine osteoblastic MC3T3-E1 cells. J Dent Res 84: 422-427. (Pubitemid 43827873)
36. Oursler MJ, Bradley EW, Elfering SL, Giulivi C,. 2005. Native, not nitrated, cytochrome c and mitochondria-derived hydrogen peroxide drive osteoclast apoptosis. Am J Physiol Cell Physiol 288: C156-C168. (Pubitemid 39658438)
37. Ozaki K, Takeda H, Iwahashi H, Kitano S, Hanazawa S,. 1997. NF-kappaB inhibitors stimulate apoptosis of rabbit mature osteoclasts and inhibit bone resorption by these cells. FEBS Lett 410: 297-300. (Pubitemid 27304083)
38. Pederson L, Ruan M, Westendorf JJ, Khosla S, Oursler MJ,. 2008. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci USA 105: 20764-20769.
39. Quinn JMW, Fujikawa Y, McGee OD, Athanasou NA,. 1997. Rodent osteoblast-like cells support osteoclastic differentiation of human cord blood monocytes in the presence of M-CSF and 1,25-dihydroxyvitamin D3. Int J Biochem Cell Biol 29: 173-179. (Pubitemid 27096430)
40. Roberts HC, Knott L, Avery NC, Cox TM, Evans MJ, Hayman AR,. 2007. Altered collagen in tartarate-resistant acid phosphatase (TRAP)-deficient mice: A role for TRAP in bone collagen metabolism. Calcif Tissue Int 80: 400-410. (Pubitemid 46956770)
41. San-Julian M, Diaz-de-Rada P, Noain E, Sierrasesumaga L,. 2003. Bone metastases from osteosarcoma. Int Orthop 27: 117-120. (Pubitemid 36693282)
42. Saunders MM, Taylor AF, Du C, Zhou Z, Pellegrini VD, Jr., Donahue HJ,. 2006. Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells. J Biomech 39: 1419-1427.
43. Taichman RS, Emerson SG,. 1996. Human osteosarcoma cell lines MG-63 and SaOS-2 produce G-CSF and GM-CSF: Identification and partial characterization of cell-associated isoforms. Exp Hematol 24: 509-517. (Pubitemid 26127501)
44. Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T, Imaizumi T,. 2005. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci 77: 3231-3241. (Pubitemid 41433323)
45. Torii Y, Hitomi K, Yamagishi Y, Tsukagoshi N,. 1996. Demonstration of alkaline phosphatase participation in the mineralization of osteoblasts by antisense RNA approach. Cell Biol Int 20: 459-464. (Pubitemid 26379884)
46. Womer RB, Frick K, Mitchell CD, Ross AH, Bishayee S, Scher CD,. 1987. PDGF induces c-myc mRNA expression in MG-63 human osteosarcoma cells but does not stimulate cell replication. J Cell Physiol 132: 65-72. (Pubitemid 17105324)
47. Yamashita M, Otsuka F, Mukai T, Yamanaka R, Otani H, Matsumoto Y, Nakamura E, Takano M, Sada KE, Makino H,. 2010. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Regul Pept 162: 99-108.
48. Yang Q, McHugh KP, Patntirapong S, Gu X, Wunderlich L, Hauschka PV,. 2008. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biol 27: 589-599.
49. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S,. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444. (Pubitemid 120014957)
50. Zhao Q, Shao J, Chen W, Li YP,. 2007. Osteoclast differentiation and gene regulation. Front Biosci 12: 2519-2529.